Special Articles: Quality of Care in the Rheumatic Diseases
Systematic review of the literature informing the systemic lupus erythematosus indicators project: Reproductive health care quality indicators
Article first published online: 28 DEC 2010
Copyright © 2011 by the American College of Rheumatology
Arthritis Care & Research
Volume 63, Issue 1, pages 17–30, January 2011
How to Cite
Gillis, J. Z., Panopalis, P., Schmajuk, G., Ramsey-Goldman, R. and Yazdany, J. (2011), Systematic review of the literature informing the systemic lupus erythematosus indicators project: Reproductive health care quality indicators. Arthritis Care Res, 63: 17–30. doi: 10.1002/acr.20327
- Issue published online: 28 DEC 2010
- Article first published online: 28 DEC 2010
- Accepted manuscript online: 23 AUG 2010 01:30PM EST
- Manuscript Accepted: 20 SEP 2010
- Manuscript Received: 22 DEC 2009
- Rosalind Russell Medical Research Center at the University of California, San Francisco
- Arthritis Foundation
- American College of Rheumatology/Research and Education Foundation
- NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases. Grant Number: K24-AR-002138
Systemic lupus erythematosus (SLE) primarily affects women of reproductive age. Here we summarize the scientific evidence supporting recently developed quality indicators (QIs) pertaining to reproductive health.
We used a modification of the RAND/UCLA Appropriateness Method to develop QIs for SLE. We performed systematic reviews of the literature pertaining to each proposed indicator. Three indicators focusing on reproductive health were included in the final set. Relevant literature was presented to an expert panel, who rated the validity and feasibility of the indicators.
Three QIs were rated as valid and feasible. These indicators specifically address laboratory testing during pregnancy in SLE, the treatment of antiphospholipid antibody syndrome, and counseling for drugs with teratogenic potential.
We used a rigorous method to develop reproductive health QIs for SLE. In the future, these indicators can be used in the assessment and delivery of care to patients with SLE.